RU2018101015A - Method for the prevention of chronic hypoxia and delayed fetal development - Google Patents

Method for the prevention of chronic hypoxia and delayed fetal development Download PDF

Info

Publication number
RU2018101015A
RU2018101015A RU2018101015A RU2018101015A RU2018101015A RU 2018101015 A RU2018101015 A RU 2018101015A RU 2018101015 A RU2018101015 A RU 2018101015A RU 2018101015 A RU2018101015 A RU 2018101015A RU 2018101015 A RU2018101015 A RU 2018101015A
Authority
RU
Russia
Prior art keywords
dose
pregnancy
prevention
day
chronic hypoxia
Prior art date
Application number
RU2018101015A
Other languages
Russian (ru)
Other versions
RU2018101015A3 (en
RU2699559C2 (en
Inventor
Розалия Семеновна Замалеева
Наталия Александровна Черепанова
Анастасия Владимировна Фризина
Лариса Ивановна Мальцева
Дмитрий Владимирович Фризин
Original Assignee
Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) filed Critical Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России)
Priority to RU2018101015A priority Critical patent/RU2699559C2/en
Publication of RU2018101015A publication Critical patent/RU2018101015A/en
Publication of RU2018101015A3 publication Critical patent/RU2018101015A3/ru
Application granted granted Critical
Publication of RU2699559C2 publication Critical patent/RU2699559C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (1)

Способ профилактики хронической гипоксии и задержки развития плода, включающий назначение медикаментозных препаратов беременным, отличающийся тем, что с 6 до 12 недель беременности женщинам группы риска назначают микронизированный прогестерон по 200 мг интравагинально 2 раза в день, витамин Д в дозе 1000 ME до конца беременности, 400 мг фолиевой кислоты, с 13 по 21 неделю назначают дипиридамол в дозе 100 мг/сут., снижают дозу прогестерона до 100 мг 2 раза в сутки, назначают комплекс полиненасыщенных жирных кислот семейства омега-3 в дозе 300 мг до 36 недель беременности, при дефиците витамина Д увеличивают дозу витамина Д до 2000 ME в день до конца беременности.A method for the prevention of chronic hypoxia and fetal developmental delay, including the prescription of medication drugs for pregnant women, characterized in that from 6 to 12 weeks of pregnancy, women at risk are prescribed micronized progesterone 200 mg intravaginally 2 times a day, vitamin D at 1000 IU before the end of pregnancy 400 mg of folic acid, from 13 to 21 weeks prescribed dipyridamole at a dose of 100 mg / day., Reduce the dose of progesterone to 100 mg 2 times a day, prescribe a complex of polyunsaturated fatty acids of the omega-3 family at a dose of 300 mg to 36 weeks pregnancy, with vitamin D deficiency, increase the dose of vitamin D to 2000 IU per day until the end of pregnancy.
RU2018101015A 2018-01-10 2018-01-10 Method for preventing chronic hypoxia and foetal development retardation RU2699559C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2018101015A RU2699559C2 (en) 2018-01-10 2018-01-10 Method for preventing chronic hypoxia and foetal development retardation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2018101015A RU2699559C2 (en) 2018-01-10 2018-01-10 Method for preventing chronic hypoxia and foetal development retardation

Publications (3)

Publication Number Publication Date
RU2018101015A true RU2018101015A (en) 2019-07-10
RU2018101015A3 RU2018101015A3 (en) 2019-07-17
RU2699559C2 RU2699559C2 (en) 2019-09-06

Family

ID=67209906

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018101015A RU2699559C2 (en) 2018-01-10 2018-01-10 Method for preventing chronic hypoxia and foetal development retardation

Country Status (1)

Country Link
RU (1) RU2699559C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2712444C1 (en) * 2019-11-11 2020-01-29 Федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный медицинский университет" Министерства здравоохранения Российской Федерации Method for prevention of preeclampsia in carriers of f2g20210a mutation with superthreshold increase of prothrombin activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2473339C1 (en) * 2011-06-03 2013-01-27 Автономное учреждение Чувашской Республики "Институт усовершенствования врачей" Министерства здравоохранения и социального развития Чувашской Республики Method of prevention or treatment of intrauterine growth retardation syndrome
RU2524653C1 (en) * 2012-12-13 2014-07-27 Элисо Мурмановна Джобава Method for correction of thrombophilic disorders accompanying pregnancy

Also Published As

Publication number Publication date
RU2018101015A3 (en) 2019-07-17
RU2699559C2 (en) 2019-09-06

Similar Documents

Publication Publication Date Title
Study et al. Lutein+ zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial
JP2014505702A5 (en)
KR20160093638A (en) Composition useful for promoting female fertility
RU2018101015A (en) Method for the prevention of chronic hypoxia and delayed fetal development
MX2020001840A (en) Maternal vitamin b2 administration for the prevention of increased adiposity, overweight or obesity in the offspring.
WO2014008465A3 (en) Potentiation of antibiotic treatment with a protein-lipid complex
PH12016500916A1 (en) Maternal vitamin b6 administration for the prevention of increased adiposity, overweight or obesity in the offspring
Kemse et al. Maternal supplementation of omega-3 fatty acids and micronutrients reduces cardiometabolic variables in pregnancy induced hypertension rats
WO2012058463A3 (en) Trimegestone (tmg) for treatment of preterm birth
UA128573U (en) METHOD OF PREVENTING PREGNANT PREGNANCY IN PREGNANT PREGNANCY WITH HYPERTENSIVE DISORDERS
EA202092105A1 (en) PHARMACEUTICAL COMPOSITION OR COMPOSITION OF A FOOD ADDITIVE BASED ON ALPHA-LACTALBUMIN
Kurmacheva et al. Clinical and economic feasibility study of the use of vitamin and mineral complexes in case of miscarriage
RU2011122690A (en) METHOD FOR PREVENTION OR TREATMENT OF SYNDROME OF DELAY OF INNERABETAL DEVELOPMENT OF THE FRUIT
RU2013115128A (en) METHOD OF TREATMENT AND TACTICS FOR MANAGEMENT OF PREGNANT WOMEN WITH DRUG HEPATITIS
UA105992U (en) Prevention of preeclampsia prevention in pregnant women with a large intergenic interval
WO2018065795A1 (en) System of multivitamin and mineral compositions for women of childbearing age
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific Opinion on the substantiation of a health claim related to increasing maternal folate status by supplemental folate intake and reduced risk of neural tube defects pursuant to Article 14 of Regulation (EC) No 1924/2006
CN105169364A (en) Vitamin complex tablet applicable to pregnant women
UA114848U (en) METHOD OF PREVENTION OF PERINATAL COMPLICATIONS IN PREGNANT PREGNANCY WITH NON-BREAKING PLACEMENT OF A NORMALLY LOCATED PLACENT
NL2018672B1 (en) Composition for use in the treatment and / or prevention of an omega-3 deficiency
PH12016500915A1 (en) Maternal vitamin b12 administration for the prevention of increased adiposity, overweight or obesity in the offspring especially offspring overweight and/or obese mothers
Bushtyreva et al. Didrogesteron use in multiple pregnancy
MD335Z (en) Method for preparing the neck of uterus for induction of delivery in pregnants with prolonged pregnancy
Lagarce Medical termination of pregnancy following premature rupture of membranes and oligohydramnios in mother and arthrogryposis in fetus: 2 case reports
Ji Various toxicities: 3 case reports

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20210111